UK Medical Research Regulators Spared the Axe
By Daniel Cressey,
Nature News Blog
| 07. 18. 2013
The future of the UK regulating bodies for human-embryo and human-tissue research has been safeguarded, as the government’s announcement yesterday that the two bodies will continue to exist brings a long-running saga to an end.
Back in 2010 the government said that it would axe the Human Fertilisation and Embryology Authority (HFEA), which regulates research on human embryos and fertility treatment. The Human Tissue Authority (HTA), which regulates other human tissue research and organ donation, was also to be wound up. The proposals were unpopular with many researchers, and
earlier this year the Department of Health announced that instead it would commission an independent review to see whether the two bodies could be merged.
That review —
published yesterday — found that there was “relatively little overlap” in the work of the two regulators and they should continue as separate bodies. This outcome has been
accepted by the government.
There will be some changes for researchers. Regulation of tissue used for developing medicinal products is to be transferred from the HTA to the UK Medicines and Healthcare Products Regulatory...
Related Articles
By Adam Feuerstein, Stat | 11.20.2025
The Food and Drug Administration was more than likely correct to reject Biohaven Pharmaceuticals’ treatment for spinocerebellar ataxia, a rare and debilitating neurodegenerative disease. At the very least, the decision announced Tuesday night was not a surprise to anyone paying attention. Approval...
By Lucy Tu, The Guardian | 11.05.2025
Beth Schafer lay in a hospital bed, bracing for the birth of her son. The first contractions rippled through her body before she felt remotely ready. She knew, with a mother’s pit-of-the-stomach intuition, that her baby was not ready either...
By Emily Glazer, Katherine Long, Amy Dockser Marcus, The Wall Street Journal | 11.08.2025
For months, a small company in San Francisco has been pursuing a secretive project: the birth of a genetically engineered baby.
Backed by OpenAI chief executive Sam Altman and his husband, along with Coinbase co-founder and CEO Brian Armstrong, the startup—called...
By Robyn Vinter, The Guardian | 11.09.2025
A man going by the name “Rod Kissme” claims to have “very strong sperm”. It may seem like an eccentric boast for a Facebook profile page, but then this is no mundane corner of the internet. The group where Rod...